Indonesia’s Medium Tank Program Features Allison Transmission

Indonesia’s Medium Tank Program Features Allison Transmission

Allison’s cross-drive transmission powers Indonesia’s Harimau (Black Tiger) Medium Tank.

INDIANAPOLIS–(BUSINESS WIRE)–
Allison Transmission, the largest global manufacturer of medium- and heavy-duty fully automatic transmissions for commercial and military vehicles, is an active participant in defense programs around the world. Most recently, Allison Transmission has proudly collaborated with Caterpillar Defense, FNSS and PT Pindad, to provide a new medium tank to the Indonesian Armed Forces, known as the Harimau. Nail Kurt, FNSS General Manager and CEO, reports planned production of between 200 and 400 of these tanks that are uniquely suited for the dense vegetation prevalent in Asia. (https://www.aa.com.tr/en/asia-pacific/turkish-indonesian-tank-ready-for-mass-production/1247122)

The Harimau is a new medium weight tank designed to increase the capability of the Armed Forces mechanized forces, providing Indonesia with the mobility and firepower capability needed in some of the most difficult terrain. The Harimau program is one of the Indonesia’s highest priority signature modernization initiatives and has passed extensive testing by both FNSS/PT Pindad and the Indonesian Armed Forces and now enters full production. The Harimau tank relies on Allison’s proven cross-drive transmission technology, designed for medium-tracked combat vehicles, and provides propulsion, steering and braking. The automatic transmission, manufactured under license by Caterpillar Defense in Shrewsbury, UK, has powered combat vehicles worldwide for decades.

“We appreciate the opportunity to provide the propulsion systems for this critically important and impressive vehicle for the Indonesian Armed Forces,” said Dana Pittard, Vice President for Defense Programs at Allison Transmission. “As we continue to support Indonesia with our world-class fully automatic transmissions, Allison is also collaborating with customers around the world to meet their current and future transmission requirements for medium weight armored vehicles. Allison Transmission is incredibly proud to collaborate with Caterpillar Defense, FNSS and PT Pindad to deliver quality products at tremendous value.”

Allison works with OEMs around the world to design, develop, manufacture and support transmissions that deliver in the most extreme conditions. For fleets that are developing new wheeled or tracked vehicles, Allison can tailor a transmission specifically for that application. Allison engineers and manufactures reliable and fully customizable propulsion solutions, so customers experience reduced downtime and increased ability to accomplish critical objectives.

About Allison Transmission

Allison Transmission (NYSE: ALSN) is a leading designer and manufacturer of vehicle propulsion solutions for commercial and defense vehicles, the largest global manufacturer of medium- and heavy-duty fully automatic transmissions, and a leader in electrified propulsion systems that Improve the Way the World Works. Allison products are used in a wide variety of applications, including on-highway trucks (distribution, refuse, construction, fire and emergency), buses (school, transit and coach), motorhomes, off-highway vehicles and equipment (energy, mining and construction applications) and defense vehicles (tactical wheeled and tracked). Founded in 1915, the company is headquartered in Indianapolis, Indiana, USA. With a presence in more than 150 countries, Allison has regional headquarters in the Netherlands, China and Brazil, manufacturing facilities in the USA, Hungary and India, as well as global engineering resources, including electrification engineering centers in Indianapolis, Indiana, Auburn Hills, Michigan and London in the United Kingdom. Allison also has more than 1,400 independent distributor and dealer locations worldwide. For more information, visit allisontransmission.com.

Claire Gregory

Director of Communications and Media Relations

[email protected]

317-695-9124

KEYWORDS: United States Indonesia North America Asia Pacific Indiana

INDUSTRY KEYWORDS: Defense Automotive Other Automotive Automotive Manufacturing Manufacturing Performance & Special Interest Other Defense

MEDIA:

Logo
Logo

LPL Financial Announces Completion of Senior Unsecured Notes Offering

SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) today announced that its wholly owned subsidiary, LPL Holdings, Inc. (“LPL Holdings”), has completed its previously announced offering of $400 million of senior unsecured notes due 2031 (the “senior notes”).

LPL Holdings used the net proceeds from the senior notes offering, together with corporate cash, to repay borrowings on its existing revolving credit facility related to its acquisition of the wealth management business of Waddell & Reed Financial, Inc. on April 30, 2021, and to pay fees and expenses related to the senior notes offering. The senior notes bear interest at a rate of 4.375% to be paid semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2021. The senior notes were priced at 100% of the aggregate principal amount, and will mature on May 15, 2031.

LPL Holdings’ outstanding indebtedness, following the senior notes offering, and after using proceeds from the offering to repay borrowings on its revolving credit facility, is summarized in the following table:

    Outstanding PrincipalAmount
(dollars inthousands)
  Current
Applicable

Margin
  Yield
At

Issuance


 
Maturity
Revolving Credit Facility (a) $   ABR + 25 bps         3/15/2026
Senior Secured Term Loan B (b)   1,056,625   LIBOR + 175 bps         11/12/2026
2027 Senior Unsecured Notes (c)   400,000   4.625% Fixed   4.625 %   11/15/2027
2029 Senior Unsecured Notes (d)   900,000   4.000% Fixed   4.000 %   3/15/2029
2031 Senior Unsecured Notes (e)   400,000   4.375% Fixed   4.375 %   5/15/2031
Total $ 2,756,625              
  1. Secured borrowing capacity of $1 billion at LPL Holdings, Inc. After using proceeds from the senior notes offering to repay borrowings on the revolving credit facility, the revolving credit facility was undrawn.
  2. The LIBOR rate option is one-month LIBOR rate and subject to an interest rate floor of 0 basis points.
  3. The Senior Unsecured Notes were issued in November 2019 at par.
  4. The Senior Unsecured Notes were issued in March 2021 at par.
  5. The Senior Unsecured Notes were issued in May 2021 at par.

LPL Holdings incurred approximately $4 million of costs as a result of the senior notes offering, which is expected to be capitalized and amortized over the life of the debt. As a result of the senior notes offering, and taking into account related costs, the Company (as defined below) estimates approximately $18 million of additional annual interest expense.

The senior notes offering was managed by an arranger group of 12 banks led by JPMorgan Chase Bank, N.A.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the senior notes. The senior notes have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The senior notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act.

Forward-Looking Statements

Statements in this press release regarding LPL Holdings’ future amortization of debt issuance costs and interest expense, as well as any other statements that are not related to present facts or current conditions or that are not purely historical, constitute forward-looking statements. These forward-looking statements are based on the Company’s historical performance and its plans, estimates, and expectations as of the date hereof. The words “expects”, “intends”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees that the future results, plans, intentions, or expectations expressed or implied will be achieved. Matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, legislative, regulatory, competitive, and other factors, which may cause actual results, or the timing of events, to be materially different from those expressed or implied by forward-looking statements. Important factors that could cause or contribute to such differences include: differences between the debt issuance costs we expect to incur and the costs that we actually incur, and potential changes to applicable accounting standards. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect the business of LPL Financial Holdings Inc. (together with its subsidiaries, the “Company”), including the risk factors set forth in Part I, “Item 1A. Risk Factors” in the Company’s 2020 Annual Report on Form 10-K, as may be amended or updated in the Company’s Quarterly Reports on Form 10-Q or other filings with the Securities and Exchange Commission. Except as required by law, the Company specifically disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release, even if its estimates change, and you should not rely on statements contained herein as representing the Company’s views as of any date subsequent to the date of this press release.

About LPL Financial

LPL Financial (https://www.lpl.com) is a leader in the retail financial advice market, the nation’s largest independent broker/dealer(+) and a leading custodian (or provider of custodial services) to RIAs. We serve independent financial advisors and financial institutions, providing them with the technology, research, clearing and compliance services, and practice management programs they need to create and grow thriving practices. LPL enables them to provide objective guidance to millions of American families seeking wealth management, retirement planning, financial planning and asset management solutions.

+ Based on total revenues, Financial Planning magazine June 1996-2020.

Securities and Advisory Services offered through LPL Financial LLC, a Registered Investment Advisor. Member FINRA/SIPC.

Investor Relations – Chris Koegel, (617) 897-4574
Media Relations – Lauren Hoyt-Williams, (980) 321-1232



Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

HANOVER, MD., May 18, 2021 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced today that management will participate in two upcoming investor conferences:

Oppenheimer Rare & Orphan Disease Summit

  May 21, 2021 (On demand presentation for registered participants and available for 1×1 meetings)
   
https://www.oppenheimer.com/events/2021/rare-orphan-disease-summit.aspx

The Benchmark Company Healthcare House Call Virtual Video 1×1 Investor Conference

  May 26, 2021 (one-on-one meetings only)
   
https://www.benchmarkcompany.com/news-events/upcoming-events

To schedule a one-on-one meeting with management, please contact your conference representative or [email protected].

About
Processa
Pharmaceuticals, Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The Company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include: PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

Forward-Looking Statements

This release contains forward-looking statements. The statements in this press release that are not purely historical are forward-looking statements which involve risks and uncertainties. Actual future performance outcomes and results may differ materially from those expressed in forward-looking statements. Please refer to the registration statement relating to the securities being sold in this offering, which identifies important risk factors which could cause actual results to differ from those contained in the forward-looking statements.

For More Information:
Michael Floyd
[email protected]
301-651-4256

James Carbonara
Hayden IR
(646) 755-7412
[email protected]



The Container Store Group, Inc. Announces Fourth Quarter and Full Fiscal 2020 Financial Results

The Container Store Group, Inc. Announces Fourth Quarter and Full Fiscal 2020 Financial Results

Fourth quarter consolidated net sales of $314.7 million, up 30.4%, including $17.7 million from the 53rd week

Fourth quarter earnings per diluted share of $0.69 and adjusted earnings per diluted share* of $0.71, compared to $0.26 in fourth quarter of fiscal 2019

Fiscal 2020 consolidated net sales of $990.1 million, up 8.1%

Fiscal 2020 earnings per diluted share of $1.17 and adjusted earnings per diluted share* of $1.24, compared to $0.30 in fiscal 2019

Fiscal 2020 operating cash flow of $138.3 million and free cash flow* of $121.1 million

COPPELL, Texas–(BUSINESS WIRE)–
The Container Store Group, Inc. (NYSE: TCS) (the “Company”), today announced financial results for the fourth quarter and fiscal year 2020 ended April 3, 2021. The fourth quarter and full fiscal year 2020 consisted of 14 weeks and 53 weeks, respectively.

For the fourth quarter of fiscal 2020:

  • Consolidated net sales were $314.7 million, an increase of 30.4% compared to the thirteen weeks ended March 28, 2020. The 53rd week contributed approximately $17.7 million in net sales.

    • Net sales in The Container Store retail business (“TCS”) were $294.2 million, up 31.3%, inclusive of a 41.6% increase in general merchandise categories and a 22.2% increase in Custom Closets.
    • Online sales increased 72.2% in the fourth quarter of fiscal 2020.
    • Elfa International AB (“Elfa”) third-party net sales were $20.5 million, up 18.8% compared to the fourth quarter of fiscal 2019; excluding the impact of foreign currency translation, Elfa third-party net sales were up 5.0%.
  • Consolidated net income increased 180.0% to $35.1 million compared to $12.5 million in the fourth quarter of fiscal 2019. Consolidated net income per diluted share (“EPS”) was $0.69 compared to $0.26 in the fourth quarter of fiscal 2019. The 53rd week contributed approximately $0.07 of incremental EPS in the fourth quarter of fiscal 2020.
  • Adjusted net income per diluted share (“Adjusted EPS”)* was $0.71, inclusive of approximately $0.07 of incremental Adjusted EPS* from the 53rd week, compared to $0.26 in the fourth quarter of fiscal 2019.
  • Adjusted EBITDA* increased 66.7% to $59.5 million in the fourth quarter of fiscal 2020 compared to $35.7 million in the fourth quarter of fiscal 2019. The 53rd week contributed approximately $5.3 million of incremental Adjusted EBITDA* in the fourth quarter of fiscal 2020.
  • Net cash provided by operating activities was $138.3 million in the fifty-three weeks ended April 3, 2021 compared to $30.7 million in the fifty-two weeks ended March 28, 2020.
  • Free cash flow* increased to $121.1 million compared to ($2.9) million in the fifty-two weeks ended March 28, 2020. In fiscal 2020, the Company utilized $78 million to pay down principal on its Senior Secured Term Loan.

Satish Malhotra, Chief Executive Officer commented, “I am very proud of our team’s accomplishments in fiscal 2020 underscored by outstanding fourth quarter performance driven by broad-based product and channel demand. I want to thank all of our teams for their hard work and dedication in driving these results despite the difficult environment created by the COVID-19 pandemic this fiscal year. In addition, these results could not have been possible without the steady leadership and resolve of my predecessor, Melissa Reiff.”

Mr. Malhotra continued, “As we look to fiscal 2021 and the next chapter for The Container Store, we have developed our strategic priorities and supporting initiatives to make this great company the best version of itself. We will strive to deepen our relationship with our customers, expand our reach, and strengthen our capabilities through continuous improvement and by being an employer of choice. All while championing the enriching benefits of living an organized life. The addressable market is substantial and our solid foundation, combined with our focused strategic priorities, positions us well to capitalize on the many opportunities we see for our business and our brand.”

Fourth Quarter Fiscal 2020 Results

For the fourth quarter (fourteen weeks) ended April 3, 2021:

  • Consolidated net sales were $314.7 million, up 30.4% compared to the fourth quarter of fiscal 2019. TCS net sales were $294.2 million, an increase of 31.3% with other product categories up 41.6%, contributing 1,940 basis points of the increase, and Custom Closets up 22.2%, contributing 1,190 basis points of the increase. Our online sales increased 72.2% compared to the fourth quarter of fiscal 2019. Elfa third-party net sales were $20.5 million, up 18.8% compared to the fourth quarter of fiscal 2019. Excluding the impact of foreign currency translation, Elfa third-party net sales were up 5.0%. As a result of the impact of the COVID-19 pandemic on our Company’s stores in the fourth quarter of fiscal 2019 and the Company’s policy of excluding extended store closures from its comparable sales calculation, the Company does not believe that comparable store sales is a meaningful metric to present for the fourth quarter of fiscal 2020.
  • Consolidated gross margin was 59.3%, an increase of 30 basis points, compared to the fourth quarter of fiscal 2019. The increase in consolidated gross margin was driven by the realization of more intercompany profit on sales of elfa® product at TCS this year as compared to last year. TCS gross margin decreased 60 basis points to 57.1%, primarily due to increased shipping costs as a result of a higher mix of online sales and an unfavorable mix of lower margin product and service sales, partially offset by less promotional activity in the fourth quarter of fiscal 2020. Elfa gross margin decreased 70 basis points primarily due to higher direct material costs.
  • Consolidated selling, general and administrative expenses (“SG&A”) increased by 16.4% to $123.4 million in the fourth quarter of fiscal 2020 from $106.1 million in the fourth quarter of fiscal 2019. SG&A as a percentage of net sales decreased 480 basis points primarily due to leverage of occupancy and payroll costs on higher sales during the quarter.
  • Stock-based compensation increased to $2.8 million in the fourth quarter of fiscal 2020 from $0.5 million in the fourth quarter of fiscal 2019. The increase was primarily due to liability accounting for a portion of performance awards that were significantly impacted by increases in our stock price during fiscal 2020 combined with achievement of fiscal 2020 performance awards at the maximum level. The increase was additionally impacted by the acceleration of expense for awards made to certain executives under employment agreements whose service periods expired in the fourth quarter of fiscal 2020.
  • Pre-opening costs declined to $0.9 million in the fourth quarter of fiscal 2020 from $2.2 million in the fourth quarter of fiscal 2019 primarily due to $2.2 million of net costs associated with the opening of the second distribution center in the fourth quarter of fiscal 2019. The Company opened one new store in the fourth quarter of fiscal 2020 and did not open any stores in the fourth quarter of fiscal 2019.
  • Consolidated net interest expense decreased 29.6% to $3.7 million in the fourth quarter of fiscal 2020 from $5.3 million in the fourth quarter of fiscal 2019. The decrease is primarily due to a lower principal balance on the Senior Secured Term Loan Facility combined with lower interest rates.
  • The effective tax rate was 25.8% in the fourth quarter of fiscal 2020, as compared to 29.7% in the fourth quarter of fiscal 2019. The decrease in the effective tax rate is primarily due to the impact of discrete items on higher pre-tax income in the fourth quarter of fiscal 2020.
  • Net income increased 180.0% to $35.1 million in the fourth quarter of fiscal 2020 compared to $12.5 million in the fourth quarter of fiscal 2019. EPS in the fourth quarter of fiscal 2020 was $0.69 compared to $0.26 in the fourth quarter of fiscal 2019. Adjusted net income* was $35.7 million, or $0.71 per diluted share, in the fourth quarter of fiscal 2020 compared to adjusted net income* of $12.5 million, or $0.26 per diluted share in the fourth quarter of fiscal 2019.
  • Adjusted EBITDA* increased 66.7% to $59.5 million in the fourth quarter of fiscal 2020 compared to $35.7 million in the fourth quarter of fiscal 2019, driven by higher consolidated net sales and a 480 basis point improvement in SG&A as a percentage of consolidated net sales as well as consolidated gross margin increase of 30 basis points.

For the year (fifty-three weeks) ended April 3, 2021:

  • Consolidated net sales were $990.1 million, up 8.1% as compared to fiscal 2019. Net sales at TCS were $923.1 million, up 8.3%, with other product categories up 10.4%, contributing 550 basis points of the increase, and Custom Closets up 5.9% contributing 280 points to the increase. Our online sales increased 109.5% compared to fiscal 2019. Elfa third-party net sales were $67.0 million, up 5.3% compared to fiscal 2019; however, excluding the impact of foreign currency translation, Elfa third-party net sales were down 2.2%. TCS and Elfa net sales were negatively impacted by COVID-19 during the first quarter of fiscal 2020. As a result of the impact of the COVID-19 pandemic on our Company’s stores and the Company’s policy of excluding extended store closures from its comparable sales calculation, the Company does not believe that comparable store sales is a meaningful metric to present for fiscal 2020.
  • Consolidated gross margin was 57.6%, a decrease of 60 basis points compared to fiscal 2019. TCS gross margin decreased 130 basis points to 56.1%, primarily due to increased shipping costs as a result of a higher mix of online sales, partially offset by a favorable mix of higher margin product and service sales. Elfa gross margin increased 310 basis points primarily due to lower direct material costs, favorable customer and product sales mix and production efficiencies.
  • Consolidated SG&A decreased by 3.1% to $426.8 million from $440.4 million in fiscal 2019. SG&A as a percentage of net sales decreased 500 basis points. The decrease was primarily due to reduced spending in payroll and marketing, combined with leverage on occupancy costs due to higher sales in fiscal 2020.
  • Stock-based compensation increased to $7.8 million in fiscal 2020 from $3.1 million in fiscal 2019. The increase was primarily due to liability accounting for a portion of performance awards that were significantly impacted by increases in our stock price during fiscal 2020 combined with the acceleration of expense for awards made to certain executives under employment agreements whose service periods expired in the fourth quarter of fiscal 2020. The increase was also impacted by fiscal 2020 performance awards that were achieved at the maximum level.
  • Pre-opening costs declined to $1.0 million in fiscal 2020 from $8.2 million in fiscal 2019 primarily due to $7.2 million of net costs associated with the opening of the second distribution center in fiscal 2019. The Company opened one new store in fiscal 2020 as compared to opening two new stores, including one relocation, in fiscal 2019.
  • Other expenses increased to $1.1 million in fiscal 2020 due to severance costs associated with the reduction in workforce as a result of the COVID-19 pandemic, as compared to $0.4 million for charges primarily related to the closure of Elfa France operations in fiscal 2019.
  • Consolidated net interest expense decreased 19.8% to $17.3 million in fiscal 2020 from $21.5 million in fiscal 2019. The decrease is primarily due to lower interest rates combined with a lower principal balance on the Senior Secured Term Loan Facility. In the third quarter of fiscal 2020, the Company amended its Senior Secured Term Loan Facility and incurred a loss on extinguishment of debt of $0.9 million.
  • The effective tax rate was 27.9% in fiscal 2020, as compared to 31.7% in fiscal 2019. The decrease in the effective tax rate is primarily due to the impact of discrete items on higher pre-tax income in fiscal 2020.
  • Net income increased 302.3% to $58.3 million in fiscal 2020 compared to $14.5 million in fiscal 2019. EPS in fiscal 2020 was $1.17 compared to $0.30 in fiscal 2019. Adjusted net income* was $61.8 million, or $1.24 per diluted share, in fiscal 2020 compared to adjusted net income* of $14.8 million, or $0.30 per diluted share in fiscal 2019.
  • Adjusted EBITDA* increased 65.7% to $150.5 million in fiscal 2020 compared to $90.8 million in fiscal 2019.

53rd Week Impact

The Company’s fiscal fourth quarter consolidated sales of $314.7 million, Adjusted EBITDA* of $59.5 million, EPS of $0.69, and Adjusted EPS* of $0.71 is inclusive of the benefit from the 53rd week, which contributed approximately $17.7 million to consolidated sales, approximately $5.3 million to Adjusted EBITDA*, and approximately $0.07 to EPS and Adjusted EPS* in the fiscal fourth quarter.

Outlook

The Company currently expects first quarter of fiscal 2021 consolidated sales growth of approximately 50% as compared to the first quarter of fiscal 2020. EPS for the first quarter of fiscal 2021 is expected to be approximately $0.08, or $0.09 on an adjusted* basis.

Balance sheet and liquidity highlights:

 

 

 

 

 

 

 

(In thousands)

 

April 3, 2021

 

March 28, 2020

Cash

 

$

17,687

 

$

67,755

 

Total debt, net of deferred financing costs

 

$

165,984

 

$

333,487

 

Liquidity (1)

 

$

126,771

 

$

96,421

 

Free cash flow (2)

 

$

121,111

 

$

(2,871

)

________________________

(1)

Cash plus availability on revolving credit facilities.

(2)

See Reconciliation of GAAP to Non-GAAP Financial Measures table.

 

Conference Call Information

A conference call to discuss fourth quarter fiscal 2020 financial results is scheduled for today, May 18, 2021, at 4:30 PM Eastern Time. Investors and analysts interested in participating in the call are invited to dial (877) 407-3982 (international callers please dial (201) 493-6780) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.containerstore.com.

A taped replay of the conference call will be available within two hours of the conclusion of the call and can be accessed both online and by dialing (844) 512-2921 (international callers please dial (412) 317-6671). The pin number to access the telephone replay is 13718355. The replay will be available until June 18, 2021.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding our future opportunities; our goals, strategies, priorities and initiatives; sales trends and momentum; and our anticipated financial performance.

These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the COVID-19 pandemic and the associated impact on our business, results of operations and financial condition; our ability to continue to lease space on favorable terms; costs and risks relating to new store openings; quarterly and seasonal fluctuations in our operating results; cost increases that are beyond our control; our inability to protect our brand; our failure or inability to protect our intellectual property rights; overall decline in the health of the economy, consumer spending, and the housing market; our inability to source and market new products to meet consumer preferences; failure to successfully anticipate consumer preferences and demand; competition from other stores and internet-based competition; vendors may sell similar or identical products to our competitors; our and our vendors’ vulnerability to natural disasters and other unexpected events; disruptions at our Elfa manufacturing facilities; deterioration or change in vendor relationships or events that adversely affect our vendors or their ability to obtain financing for their operations, including COVID-19; product recalls and/or product liability, as well as changes in product safety and other consumer protection laws; risks relating to operating two distribution centers; our dependence on foreign imports for our merchandise; our reliance upon independent third party transportation providers; our inability to effectively manage our online sales; effects of a security breach or cyber-attack of our website or information technology systems, including relating to our use of third-party web service providers; damage to, or interruptions in, our information systems as a result of external factors, working from home arrangements, staffing shortages and difficulties in updating our existing software or developing or implementing new software; our indebtedness may restrict our current and future operations, and we may not be able to refinance our debt on favorable terms, or at all; fluctuations in currency exchange rates; our inability to maintain sufficient levels of cash flow to meet growth expectations; our fixed lease obligations; disruptions in the global financial markets leading to difficulty in borrowing sufficient amounts of capital to finance the carrying costs of inventory to pay for capital expenditures and operating costs; changes to global markets and inability to predict future interest expenses; our reliance on key executive management; our inability to find, train and retain key personnel; labor relations difficulties; increases in health care costs and labor costs; violations of the U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery and anti-kickback laws; impairment charges and effects of changes in estimates or projections used to assess the fair value of our assets; effects of tax reform and other tax fluctuations; and significant fluctuations in the price of our common stock; substantial future sales of our common stock, or the perception that such sales may occur, which could depress the price of our common stock; risks related to being a public company; our performance meeting guidance provided to the public; anti-takeover provisions in our governing documents, which could delay or prevent a change in control; and our failure to establish and maintain effective internal controls.

These and other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, (the “SEC”) on June 17, 2020 and our other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

About The Container Store

The Container Store Group, Inc. (NYSE: TCS) is the nation’s leading retailer of storage and organization products and solutions – a concept they originated in 1978. Today, with locations nationwide, the retailer offers more than 11,000 products designed to help customers accomplish projects, maximize their space and make the most of their home. The Container Store also offers a full suite of custom closets designed to accommodate all sizes, styles and budgets.

Visit www.containerstore.com for more information about store locations, the product collection and services offered. Visit www.containerstore.com/blog for inspiration, tips and real solutions to everyday organization challenges, and www.whatwestandfor.com to learn more about the company’s unique culture.

* See Reconciliation of GAAP to Non-GAAP Financial Measures table.

The Container Store Group, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statements of operations

 

 

Fiscal Quarter Ended

 

Fiscal Year Ended

(In thousands, except share and per share amounts)

 

April 3, 2021

 

March 28, 2020

 

April 3, 2021

 

March 28, 2020

 

 

 

(unaudited)

 

 

 

 

 

(unaudited)

 

 

 

Net sales

 

$

314,683

 

$

241,344

 

$

990,088

 

$

915,953

 

Cost of sales (excluding depreciation and amortization)

 

 

127,990

 

 

98,855

 

 

419,611

 

 

382,488

 

Gross profit

 

 

186,693

 

 

142,489

 

 

570,477

 

 

533,465

 

Selling, general, and administrative expenses (excluding depreciation and amortization)

 

 

123,437

 

 

106,081

 

 

426,765

 

 

440,362

 

Stock-based compensation

 

 

2,837

 

 

535

 

 

7,823

 

 

3,110

 

Pre-opening costs

 

 

915

 

 

2,249

 

 

1,026

 

 

8,237

 

Depreciation and amortization

 

 

8,461

 

 

10,501

 

 

34,731

 

 

38,638

 

Other expenses

 

 

23

 

 

2

 

 

1,112

 

 

377

 

Loss (gain) on disposal of assets

 

 

4

 

 

10

 

 

16

 

 

(2

)

Income from operations

 

 

51,016

 

 

23,111

 

 

99,004

 

 

42,743

 

Interest expense, net

 

 

3,728

 

 

5,296

 

 

17,268

 

 

21,541

 

Loss on extinguishment of debt

 

 

 

 

 

 

893

 

 

 

Income before taxes

 

 

47,288

 

 

17,815

 

 

80,843

 

 

21,202

 

Provision for income taxes

 

 

12,204

 

 

5,287

 

 

22,560

 

 

6,715

 

Net income

 

$

35,084

 

$

12,528

 

$

58,283

 

$

14,487

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per common share — basic

 

$

0.72

 

$

0.26

 

$

1.20

 

$

0.30

 

Net income per common share — diluted

 

$

0.69

 

$

0.26

 

$

1.17

 

$

0.30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares — basic

 

 

48,667,689

 

 

48,316,559

 

 

48,537,883

 

 

48,819,783

 

Weighted-average common shares — diluted

 

 

50,537,033

 

 

48,397,919

 

 

49,712,637

 

 

48,964,564

 

 

The Container Store Group, Inc.

 

 

 

 

 

 

 

Consolidated balance sheets

 

 

April 3,

 

March 28,

 

(In thousands)

 

2021

 

2020

 

Assets

 

(unaudited)

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash

 

$

17,687

 

$

67,755

 

Accounts receivable, net

 

 

28,949

 

 

24,721

 

Inventory

 

 

130,619

 

 

124,207

 

Prepaid expenses

 

 

11,429

 

 

8,852

 

Income taxes receivable

 

 

93

 

 

4,724

 

Other current assets

 

 

14,547

 

 

11,907

 

Total current assets

 

 

203,324

 

 

242,166

 

Noncurrent assets:

 

 

 

 

 

 

 

Property and equipment, net

 

 

131,884

 

 

147,540

 

Noncurrent operating lease right-of-use assets

 

 

307,147

 

 

347,170

 

Goodwill

 

 

202,815

 

 

202,815

 

Trade names

 

 

227,669

 

 

222,769

 

Deferred financing costs, net

 

 

255

 

 

170

 

Noncurrent deferred tax assets, net

 

 

2,305

 

 

2,311

 

Other assets

 

 

3,070

 

 

1,873

 

Total noncurrent assets

 

 

875,145

 

 

924,648

 

Total assets

 

$

1,078,469

 

$

1,166,814

 

 

The Container Store Group, Inc.

 

 

 

 

 

 

 

Consolidated balance sheets (continued)

 

 

April 3,

 

March 28,

 

(In thousands, except share and per share amounts)

 

2021

 

 

2020

 

 

Liabilities and shareholders’ equity

 

(unaudited)

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

 

$

68,546

 

 

$

53,647

 

 

Accrued liabilities

 

 

86,551

 

 

 

66,046

 

 

Current borrowings on revolving lines of credit

 

 

 

 

 

9,050

 

 

Current portion of long-term debt

 

 

2,166

 

 

 

6,952

 

 

Current operating lease liabilities

 

 

50,847

 

 

 

62,476

 

 

Income taxes payable

 

 

6,803

 

 

 

 

 

Total current liabilities

 

 

214,913

 

 

 

198,171

 

 

Noncurrent liabilities:

 

 

 

 

 

 

 

Long-term debt

 

 

163,818

 

 

 

317,485

 

 

Noncurrent operating lease liabilities

 

 

285,022

 

 

 

317,284

 

 

Noncurrent deferred tax liabilities, net

 

 

48,923

 

 

 

50,178

 

 

Other long-term liabilities

 

 

12,124

 

 

 

11,988

 

 

Total noncurrent liabilities

 

 

509,887

 

 

 

696,935

 

 

Total liabilities

 

 

724,800

 

 

 

895,106

 

 

Commitments and contingencies

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

Common stock, $0.01 par value, 250,000,000 shares authorized; 48,838,261 shares issued at April 3, 2021 and 48,316,559 shares issued at March 28, 2020

 

 

488

 

 

 

483

 

 

Additional paid-in capital

 

 

873,048

 

 

 

866,667

 

 

Accumulated other comprehensive loss

 

 

(19,003

)

 

 

(36,295

)

 

Retained deficit

 

 

(500,864

)

 

 

(559,147

)

 

Total shareholders’ equity

 

 

353,669

 

 

 

271,708

 

 

Total liabilities and shareholders’ equity

 

$

1,078,469

 

 

$

1,166,814

 

 

 

The Container Store Group, Inc.

 

 

 

 

 

 

Consolidated statements of cash flows

 

 

Fiscal Year Ended

 

 

April 3,

 

March 28,

(In thousands)

 

2021

 

2020

 

 

 

(unaudited)

 

 

 

Operating activities

 

 

 

 

 

 

Net income

 

$

58,283

 

 

$

14,487

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

34,731

 

 

 

38,638

 

Stock-based compensation

 

 

7,823

 

 

 

3,110

 

Loss (gain) on disposal of assets

 

 

16

 

 

 

(2

)

Loss on extinguishment of debt

 

 

893

 

 

 

 

Deferred tax benefit

 

 

(4,740

)

 

 

148

 

Non-cash interest

 

 

1,870

 

 

 

1,862

 

Other

 

 

161

 

 

 

316

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(1,497

)

 

 

(1,002

)

Inventory

 

 

(2,403

)

 

 

(17,293

)

Prepaid expenses and other assets

 

 

(2,193

)

 

 

1,089

 

Accounts payable and accrued liabilities

 

 

35,203

 

 

 

(3,531

)

Net change in lease assets and liabilities

 

 

(4,118

)

 

 

49

 

Income taxes

 

 

11,346

 

 

 

(6,876

)

Other noncurrent liabilities

 

 

2,912

 

 

 

(247

)

Net cash provided by operating activities

 

 

138,287

 

 

 

30,748

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Additions to property and equipment

 

 

(17,176

)

 

 

(33,619

)

Proceeds from sale of property and equipment

 

 

65

 

 

 

17

 

Net cash used in investing activities

 

 

(17,111

)

 

 

(33,602

)

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

Borrowings on revolving lines of credit

 

 

56,132

 

 

 

63,603

 

Payments on revolving lines of credit

 

 

(66,227

)

 

 

(59,585

)

Borrowings on long-term debt

 

 

200,000

 

 

 

115,000

 

Payments on long-term debt

 

 

(355,954

)

 

 

(54,251

)

Payment of debt issuance costs

 

 

(5,579

)

 

 

 

Payment of taxes with shares withheld upon restricted stock vesting

 

 

(931

)

 

 

(373

)

Proceeds from the exercise of stock options

 

 

496

 

 

 

 

Net cash (used in) provided by financing activities

 

 

(172,063

)

 

 

64,394

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

819

 

 

 

(1,149

)

 

 

 

 

 

 

 

Net (decrease) increase in cash

 

 

(50,068

)

 

 

60,391

 

Cash at beginning of fiscal period

 

 

67,755

 

 

 

7,364

 

Cash at end of fiscal period

 

$

17,687

 

 

$

67,755

 

 

Note Regarding Non-GAAP Information

This press release includes financial measures that are not calculated in accordance with GAAP, including adjusted net income, adjusted net income per common share – diluted, Adjusted EBITDA, and free cash flow. The Company has reconciled these non-GAAP financial measures with the most directly comparable GAAP financial measures in a table accompanying this release. These non-GAAP measures should not be considered as alternatives to net income as a measure of financial performance or cash flows from operations as a measure of liquidity, or any other performance measure derived in accordance with GAAP and they should not be construed as an inference that the Company’s future results will be unaffected by unusual or non-recurring items. These non-GAAP measures are key metrics used by management, the Company’s board of directors, and Leonard Green and Partners, L.P., to assess its financial performance.

The Company presents adjusted net income, adjusted net income per common share – diluted, and Adjusted EBITDA because it believes they assist investors in comparing the Company’s performance across reporting periods on a consistent basis by excluding items that the Company does not believe are indicative of its core operating performance and because the Company believes it is useful for investors to see the measures that management uses to evaluate the Company. These non-GAAP measures are also frequently used by analysts, investors and other interested parties to evaluate companies in the Company’s industry. In evaluating these non-GAAP measures, you should be aware that in the future the Company will incur expenses that are the same as or similar to some of the adjustments in this presentation. The Company’s presentation of these non-GAAP measures should not be construed to imply that its future results will be unaffected by any such adjustments. Management compensates for these limitations by relying on our GAAP results in addition to using non-GAAP measures supplementally. These non-GAAP measures are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation.

The Company defines adjusted net income as net income before restructuring charges, charges related to the impact of COVID-19 on business operations, credits pursuant to the Coronavirus Aid, Relief and Economic Security (“CARES”) Act, severance charges associated with COVID-19, charges related to an Elfa manufacturing facility closure, charges related to the closure of Elfa France operations, impairment charges related to intangible assets, loss on extinguishment of debt, certain (gains) losses on disposal of assets, certain management transition costs incurred and benefits realized, charges incurred as part of the implementation of our optimization plan, and the tax impact of these adjustments and other unusual or infrequent tax items. We define adjusted net income per common share – diluted as adjusted net income divided by the diluted weighted average common shares outstanding. We use adjusted net income and adjusted net income per common share – diluted to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions and to compare our performance against that of other peer companies using similar measures. We present adjusted net income and adjusted net income per common share – diluted because we believe they assist investors in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company.

The Company defines EBITDA as net income before interest, taxes, depreciation, and amortization. Adjusted EBITDA is calculated in accordance with its credit facilities and is one of the components for performance evaluation under its executive compensation programs. Adjusted EBITDA reflects further adjustments to EBITDA to eliminate the impact of certain items, including certain non-cash and other items that the Company does not consider in its evaluation of ongoing operating performance from period to period as discussed further below. The Company uses Adjusted EBITDA in connection with covenant compliance and executive performance evaluations, and to supplement GAAP measures of performance to evaluate the effectiveness of its business strategies, to make budgeting decisions and to compare its performance against that of other peer companies using similar measures. The Company believes it is useful for investors to see the measures that management uses to evaluate the Company, its executives and its covenant compliance. EBITDA and Adjusted EBITDA are also frequently used by analysts, investors and other interested parties to evaluate companies in the Company’s industry.

The Company presents free cash flow, which the Company defines as net cash provided by operating activities in a period minus payments for property and equipment made in that period, because it believes it is a useful indicator of the Company’s overall liquidity, as the amount of free cash flow generated in any period is representative of cash that is available for debt repayment, investment, and other discretionary and non-discretionary cash uses. Accordingly, we believe that free cash flow provides useful information to investors in understanding and evaluating our liquidity in the same manner as management. Our definition of free cash flow is limited in that it does not solely represent residual cash flows available for discretionary expenditures due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our Consolidated Statements of Cash Flows. Although other companies report their free cash flow, numerous methods may exist for calculating a company’s free cash flow. As a result, the method used by our management to calculate our free cash flow may differ from the methods used by other companies to calculate their free cash flow.

Additionally, this press release refers to the change in Elfa third-party net sales after the conversion of Elfa’s net sales from Swedish krona to U.S. dollars using the prior year’s conversion rate, which is a financial measure not calculated in accordance with GAAP. The Company believes the disclosure of the change in Elfa third-party net sales without the effects of currency exchange rate fluctuations helps investors understand the Company’s underlying performance.

The Container Store Group, Inc. Supplemental Information – Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except share and per share amounts)

(unaudited)

The table below reconciles the non-GAAP financial measures of adjusted net income and adjusted net income per common share – diluted with the most directly comparable GAAP financial measures of GAAP net income and GAAP net income per common share – diluted.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal

 

Fiscal

 

Fiscal

 

Quarter Ended

 

Year Ended

 

Outlook

 

April 3, 2021

 

March 28,

2020

 

April 3, 2021

 

March 28,

2020

 

Q1’2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

35,084

 

$

12,528

 

$

58,283

 

 

$

14,487

 

 

$

4,000

 

 

Management transition costs (a)

 

 

 

 

 

1,200

 

 

 

 

 

 

150

 

 

Loss on extinguishment of debt (b)

 

 

 

 

 

893

 

 

 

 

 

 

 

 

Elfa France closure (c)

 

 

 

 

 

 

 

 

402

 

 

 

 

 

Employee retention credit (d)

 

 

 

 

 

(1,028

)

 

 

 

 

 

 

 

COVID-19 costs (e)

 

403

 

 

 

 

2,266

 

 

 

 

 

 

550

 

 

Severance (f)

 

23

 

 

 

 

1,111

 

 

 

 

 

 

 

 

Taxes (g)

 

168

 

 

 

 

(935

)

 

 

(112

)

 

 

(200

)

 

Adjusted net income

$

35,678

 

$

12,528

 

$

61,790

 

 

$

14,777

 

 

$

4,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding — diluted

 

50,537,033

 

 

48,397,919

 

 

49,712,637

 

 

 

48,964,564

 

 

 

51,000,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per common share — diluted

$

0.69

 

$

0.26

 

$

1.17

 

 

$

0.30

 

 

$

0.08

 

 

Adjusted net income per common share — diluted

$

0.71

 

$

0.26

 

$

1.24

 

 

$

0.30

 

 

$

0.09

 

 

________________________

(a)

Costs related to the transition of key executives including signing bonus and relocation expenses recorded as selling, general and administrative expenses, which we do not consider in our evaluation of ongoing performance.

(b)

Loss recorded as a result of the Seventh Amendment made to the Senior Secured Term Loan Facility in the third quarter of fiscal 2020, which we do not consider in our evaluation of our ongoing performance.

(c)

Charges related to the closure of Elfa France operations in the second quarter of fiscal 2019, which we do not consider in our evaluation of ongoing performance.

(d)

Employee retention credit related to the CARES Act recorded in the third quarter of fiscal 2020 as selling, general and administrative expense which we do not consider in our evaluation of ongoing performance.

(e)

Includes incremental costs attributable to the COVID-19 pandemic, which consist of hazard pay for distribution center employees in the first quarter of fiscal 2020 and sanitization costs in fiscal 2020, all of which are recorded as selling, general and administrative expenses which we do not consider in our evaluation of ongoing performance.

(f)

Includes costs primarily incurred in the first and second quarters of fiscal 2020 associated with the reduction in workforce as a result of the COVID-19 pandemic and the related temporary store closures in fiscal 2020, which we do not consider in our evaluation of ongoing performance.

(g)

Tax impact of adjustments to net income that are considered to be unusual or infrequent tax items, all of which we do not consider in our evaluation of ongoing performance.

The table below reconciles the non-GAAP financial measure Adjusted EBITDA with the most directly comparable GAAP financial measure of GAAP net income.

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Quarter Ended

 

Fiscal Year Ended

 

April 3, 2021

 

March 28, 2020

 

April 3, 2021

 

March 28, 2020

Net income

$

35,084

 

 

$

12,528

 

 

$

58,283

 

 

$

14,487

 

Depreciation and amortization

 

8,461

 

 

 

10,501

 

 

 

34,731

 

 

 

38,638

 

Interest expense, net

 

3,728

 

 

 

5,296

 

 

 

17,268

 

 

 

21,541

 

Income tax provision

 

12,204

 

 

 

5,287

 

 

 

22,560

 

 

 

6,715

 

EBITDA

$

59,477

 

 

$

33,612

 

 

$

132,842

 

 

$

81,381

 

Pre-opening costs (a)

 

915

 

 

 

2,249

 

 

 

1,026

 

 

 

8,237

 

Non-cash lease expense (b)

 

(4,164

)

 

 

(637

)

 

 

4,147

 

 

 

(2,169

)

Stock-based compensation (c)

 

2,837

 

 

 

535

 

 

 

7,823

 

 

 

3,110

 

Management transition costs (d)

 

 

 

 

 

 

 

1,200

 

 

 

 

Loss on extinguishment of debt (e)

 

 

 

 

 

 

 

893

 

 

 

 

Foreign exchange (gains) losses (f)

 

(2

)

 

 

(69

)

 

 

200

 

 

 

(167

)

Elfa France closure (g)

 

 

 

 

 

 

 

 

 

 

402

 

Employee retention credit (h)

 

 

 

 

 

 

 

(1,028

)

 

 

 

COVID-19 costs (i)

 

403

 

 

 

 

 

 

2,266

 

 

 

 

Severance and other costs (credits) (j)

 

66

 

 

 

5

 

 

 

1,154

 

 

 

(23

)

Adjusted EBITDA

$

59,532

 

 

$

35,695

 

 

$

150,523

 

 

$

90,771

 

________________________

(a)

Non-capital expenditures associated with opening new stores and relocating stores, and costs associated with opening the second distribution center, including marketing expenses, travel and relocation costs, and training costs. We adjust for these costs to facilitate comparisons of our performance from period to period.

(b)

Reflects the extent to which our annual GAAP operating lease expense has been above or below our cash operating lease payments. The amount varies depending on the average age of our lease portfolio (weighted for size), as our GAAP operating lease expense on younger leases typically exceeds our cash operating lease payments, while our GAAP operating lease expense on older leases is typically less than our cash operating lease payments. Non-cash lease expense increased in fiscal 2020 due to renegotiated terms with landlords due to COVID-19 that resulted in deferral of $11.9 million of certain cash lease payments, of which $4.7 million remains deferred as of April 3, 2021, and the modification of certain lease terms for a substantial portion of our leased properties. In the thirteen and fifty-two weeks ended March 28, 2020, lease expenses associated with the opening of the second distribution center were excluded from Non-cash lease expense and included in Pre-opening costs.

(c)

Non-cash charges related to stock-based compensation programs, which vary from period to period depending on volume and vesting timing of awards. We adjust for these charges to facilitate comparisons from period to period.

(d)

Costs related to the transition of key executives including signing bonus and relocation expenses recorded as selling, general and administrative expenses, which we do not consider in our evaluation of ongoing performance.

(e)

Loss recorded as a result of the Seventh Amendment made to the Senior Secured Term Loan Facility in the third quarter of fiscal 2020, which we do not consider in our evaluation of our ongoing performance.

(f)

Realized foreign exchange transactional gains/losses our management does not consider in our evaluation of our ongoing operations.

(g)

Charges related to the closure of Elfa France operations in the second quarter of fiscal 2019, which we do not consider in our evaluation of ongoing performance.

(h)

Employee retention credit related to the CARES Act recorded in the third quarter of fiscal 2020 as selling, general and administrative expense which we do not consider in our evaluation of ongoing performance.

(i)

Includes incremental costs attributable to the COVID-19 pandemic, which consist of hazard pay for distribution center employees in the first quarter of fiscal 2020 and sanitization costs in fiscal 2020, all of which are recorded as selling, general and administrative expenses which we do not consider in our evaluation of ongoing performance.

(j)

Severance and other credits/costs include amounts our management does not consider in our evaluation of our ongoing operations. The fiscal 2020 amounts include costs primarily incurred in the first and second quarters of fiscal 2020 associated with the reduction in workforce as a result of the COVID-19 pandemic and the related temporary store closures in fiscal 2020.

The table below reconciles the non-GAAP financial measure of free cash flow with the most directly comparable GAAP financial measure of net cash provided by operating activities.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year Ended

 

 

April 3,

 

March 28,

 

 

2021

 

 

2020

 

Net cash provided by operating activities

 

$

138,287

 

 

$

30,748

 

Less: Additions to property and equipment

 

 

(17,176

)

 

 

(33,619

)

Free cash flow

 

$

121,111

 

 

$

(2,871

)

 

Investors:

ICR, Inc.

Farah Soi/Caitlin Morahan

203-682-8200

[email protected]

[email protected]

or

Media:

The Container Store Group, Inc.

Katelyn Clinton, 972-538-6491

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Office Products Home Goods Online Retail Other Retail Retail

MEDIA:

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kadmon Holdings, Inc. Investors to Secure Counsel Before Important June 2 Deadline in Securities Class Action – KDMN

NEW YORK, May 18, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and March 10, 2021, inclusive (the “Class Period”) of the important June 2, 2021 lead plaintiff deadline.

SO WHAT: If you purchased Kadmon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Kadmon class action, go to http://www.rosenlegal.com/cases-register-2073.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 2, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the New Drug Application for belumosudil for the treatment of chronic graft-versus-host disease (cGVHD) (the “Belumosudil NDA”) with the U.S. Food and Drug Administration (“FDA”) was incomplete and/or deficient; (2) the additional new data that Kadmon submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the Belumosudil NDA submission; (3) accordingly, the initial Belumosudil NDA submission lacked the degree of support that Kadmon had led investors to believe; (4) accordingly, the FDA was likely to extend the Prescription Drug User Fee Act (“PDUFA”) target action date to review the Belumosudil NDA; and (5) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Kadmon class action, go to http://www.rosenlegal.com/cases-register-2073.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        [email protected]
        [email protected]
        www.rosenlegal.com



Credit Acceptance Named to the 2021 Nevada Top Workplaces List

Southfield, Michigan, May 18, 2021 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) has been awarded a 2021 Top Workplaces honor by the Las Vegas Review-Journal and the Las Vegas Business Press. This is the second year in a row that Credit Acceptance has received this honor.

Our inclusion on this list was based solely on the results of a team member survey administered by Energage, LLC, an employee research and culture technology firm. Several aspects of our workplace culture and organizational health were measured, including alignment, execution, and connection, just to name a few.

This is the third workplace award that we’ve received this year as we also received:

  • Best Workplaces in Financial Services & Insurance (last seven years in a row)
  • 2021 Top Workplaces USA Award


About Credit Acceptance

Since 1972, Credit Acceptance has offered financing programs that enable automobile dealers to sell vehicles to consumers, regardless of their credit history. Our financing programs are offered through a nationwide network of automobile dealers who benefit from sales of vehicles to consumers who otherwise could not obtain financing; from repeat and referral sales generated by these same customers; and from sales to customers responding to advertisements for our financing programs, but who actually end up qualifying for traditional financing.

Without our financing programs, consumers are often unable to purchase vehicles or they purchase unreliable ones. Further, as we report to the three national credit reporting agencies, an important ancillary benefit of our programs is that we provide consumers with an opportunity to improve their lives by improving their credit score and move on to more traditional sources of financing. Credit Acceptance is publicly traded on the Nasdaq stock market under the symbol CACC.  For more information, visit creditacceptance.com.


About Energage

Energage is a purpose-driven company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 14 years of culture research and the results from 23 million employees surveyed across more than 70,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. 



Investor Relations: Douglas W. Busk
Chief Treasury Officer
(248) 353-2700 Ext. 4432
[email protected]

Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Credit Suisse Group AG Investors of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., May 18, 2021 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Southern District of New York against Credit Suisse Group AG (NYSE: CS) (“Credit Suisse”) on behalf of those who purchased or acquired Credit Suisse American Depositary Receipts (“ADRs”) between October 29, 2020 and March 31, 2021, inclusive (the “Class Period”).


Investor Deadline Reminder: Investors who purchased or acquired Credit Suisse ADRs


during the Class Period may,



no later than June 15, 2021



, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at

[email protected]; orclick https://www.ktmc.com/credit-suisse-class-action-lawsuit?utm_source=PR&utm_medium=Link&utm_campaign=credit_suisse

Credit Suisse is a global financial services company based in Zurich, Switzerland. Greensill Capital (“Greensill”), who for filed for insolvency protection on March 8, 2021, was a financial services company based in the United Kingdom and Australia focused on the provision of supply-chain financing and related services. Archegos Capital Management (“Archegos”) is a family office investment fund run by Sung Kook Hwang.

On March 1, 2021, Credit Suisse froze $10 billion in funds that were invested in Greensill’s financial products and held by its supply-chain investment funds. On March 8, 2021, Greensill filed for insolvency protection, as it found itself unable to repay a $140 million loan to Credit Suisse. By March 10, 2021, media reports revealed that Greensill investors had retained counsel and intended to sue Credit Suisse for their losses because Credit Suisse continued to market the biggest of the funds as a fully insured, low-risk product despite a decision by insurers during the summer of 2020 not to renew coverage. As the market digested this news, the market price of Credit Suisse ADRs fell from its close of $14.70 per ADR on March 1, 2021 to close at $12.85 per ADR by March 12, 2021, a decline of almost 13%.

Then, on Friday, March 26, 2021, several of the large banks offering prime brokerage services to Archegos – including Morgan Stanley, Goldman Sachs and UBS – suddenly began liquidating billions of dollars’ worth of shares that Archegos had swap positions on at fire sale prices after Archegos had failed to meet a margin call. By the time Credit Suisse tried to liquidate its own holdings of stocks underlying Archegos’ swap contracts over the ensuing weekend, prices had already collapsed and Credit Suisse quickly racked up billions of dollars in losses. Credit Suisse issued a press release on March 29, 2021 conceding that “the loss resulting from this exit . . . could be highly significant and material to our first quarter results.” The Financial Times then pegged Credit Suisse’s estimated losses at between $3 billion and $5 billion, more than a year’s worth of Credit Suisse’s net profit. The market price of Credit Suisse ADRs fell another nearly 20% following this news, declining from a close of $13.21 per ADR on March 25, 2021 to close at $10.60 per ADR on March 31, 2021.

The complaint alleges that throughout the Class Period, the defendants concealed material defects in Credit Suisse’s risk policies and procedures and compliance oversight functions and efforts to allow high-risk clients to take on excessive leverage, including Greensill and Archegos, exposing Credit Suisse to billions of dollars in losses.

Credit Suisse investors may, no later than June 15, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]



ATCO Australia Pivots to the Cloud with OpenText

PR Newswire

Australian energy company modernizes work for improved continuity and cost savings

WATERLOO, ON, May 18, 2021 /PRNewswire/ — OpenText (NASDAQ: OTEX), (TSX: OTEX), today announced ATCO Australia has moved their information management solutions to the OpenText™ Cloud to modernize work for improved flexibility and cost savings.

ATCO Australia is an energy company responsible for developing, building, owning and operating energy infrastructure assets. Operating in a highly regulated industry, ATCO uses OpenText™ Extended ECM Platform to manage, secure and govern their information assets, from legal and operational documents to contracts and work orders. Recently, the company shifted their information management system from on-premises to the OpenText™ Content Cloud to gain efficiency.

“With OpenText Cloud Managed Services, we no longer have to maintain infrastructure or worry about upgrades and patches,” said Chris Marshall, General Manager IT at ATCO Australia. “We use the cloud service to access and govern documents in our information management system, which OpenText looks after for us. By moving to the cloud, access speeds are much faster—almost twice as fast. Additionally, we are now using the latest features and functionality with integration into leading business applications like Microsoft 365.”

OpenText™ Cloud Managed Services helps organizations modernize their IT by leveraging the expertise of seasoned professionals. OpenText manages the deployment, integration, ongoing management and optimization of Information Management applications and infrastructure — with the flexibility to deploy in the OpenText™ Cloud or with an OpenText public cloud partner, including Google Cloud, Microsoft Azure, or Amazon Web Services.

“ATCO Australia has made incredible progress with their information management strategy and OpenText is proud to support them on their journey to The Ultimate Cloud,” said Muhi Majzoub, Chief Product Officer at OpenText. “Our Cloud Managed Services helps organizations optimize their daily operations, freeing up their resources to focus on business, growth and innovation.”

Additionally, remote access to documentation and external sharing was essential to keep ATCO’s operations running smoothly during the pandemic. With the Extended ECM mobile app, employees have access to information stored in OpenText Extended ECM from anywhere, on almost any device. OpenText™ Core Share enables field workers to access and share up-to-date information, including safety procedures.

Learn more about OpenText Cloud Managed Services here.

About OpenText
OpenText, The Information Company™, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions. For more information about OpenText (NASDAQ: OTEX, TSX: OTEX) visit opentext.com

Connect with us:

OpenText CEO Mark Barrenechea’s blog 
Twitter | LinkedIn

Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText’s current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText’s assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright © 2021 Open Text. All Rights Reserved. Trademarks owned by Open Text. One or more patents may cover this product(s). For more information, please visit https://www.opentext.com/patents.

OTEX-G

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/atco-australia-pivots-to-the-cloud-with-opentext-301294092.html

SOURCE Open Text Corporation

Kirkland’s Announces Dates For First Quarter 2021 Earnings

PR Newswire

NASHVILLE, Tenn., May 18, 2021 /PRNewswire/ — Kirkland’s, Inc. (NASDAQ: KIRK) today announced it will issue its earnings release for the first quarter of fiscal 2021 before the market opens on Tuesday, June 1, 2021, and will host a conference call on the same day at 9:00 a.m. ET. The number to call for the interactive teleconference is (412) 542-4163. A replay of the conference call will be available through Tuesday, June 8, 2021, by dialing (412) 317-0088 and entering the confirmation number, 10156366.

A live webcast of Kirkland’s quarterly conference call will be available online on the Company’s Investor Relations Page on June 1, 2021, beginning at 9:00 a.m. ET. The online replay will follow shortly after the call and continue for one year.

About Kirkland’s, Inc.

Kirkland’s, Inc. is a specialty retailer of home décor in the United States, currently operating 370 stores in 35 states as well as an e-commerce website, www.kirklands.com. The Company’s stores present a curated selection of distinctive merchandise, including holiday décor, furniture, textiles, wall décor, decorative accessories, art, mirrors, fragrances, and other home decorating items. The Company’s stores offer an extensive assortment of holiday merchandise during seasonal periods. The Company provides its customers an engaging shopping experience characterized by affordable home décor and inspirational design ideas. This combination of quality and stylish merchandise, value pricing and a stimulating online and store experience allows our customer to furnish their home on a budget. More information can be found at www.kirklands.com.

Contact:        

Kirkland’s      

Kirkland’s            

Nicole Strain         

Investor Relations

(615) 872-4800                    


[email protected]

(615) 872-4898

           

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/kirklands-announces-dates-for-first-quarter-2021-earnings-301294127.html

SOURCE Kirkland’s, Inc.

Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting

Study
uses mobile device technology to support capture of patient

reported outcomes during early
and
ongoing
use of stud
y
treatment
amongst patients with rheumatoid arthritis

Mechelen
, Belgium
;
18
May
2021
;
22.0
1
CET
;

Galapagos NV (Euronext & Nasdaq: GLPG) today announced
that the first patient has been enrolled
i
n the FILOSOPHY
P
hase 4 European real-world outcomes study
. The goal
of the FILOSOPHY study
is
to advance understanding of the effectiveness and safety of filgotinib as it is used
with patients with
r
heumatoid
a
rthritis (RA)
in clinical practice.

The study, with target enrollment of 1500 patients across Europe, will evaluate the effectiveness, safety, and patient-reported outcomes (PROs) in patients with moderate to severe active RA while receiving filgotinib in a real-world setting for up to two years. Mobile device technology will play a central role in collection of PROs, allowing data collection to begin within the first weeks of treatment. This may also prove to be an effective tool during the pandemic, while in-person clinic visits are harder to achieve.

FILOSOPHY will enable the gathering of comprehensive real-world data in a population that may not be fully represented in clinical trials, as randomized, placebo-controlled trials require strict patient inclusion criteria. These data will expand the evidence base to support the appropriate use of filgotinib in clinical practice.

Dr. Walid Abi-Saab, Chief Medical Officer of Galapagos said, “This study can enhance our understanding about the effectiveness and safety of filgotinib from the experiences of RA patients who are prescribed the treatment in a real-world healthcare setting. We aim to improve disease management and outcomes for people living with this debilitating condition.”

Professor Gerd Burmester, Director Department of Rheumatology and Clinical Immunology, Charité, Universitätsmedizin, Berlin and FILOSOPHY Steering Committee Member, added, “We expect that use of remote devices to collect treatment outcomes data will give us more comprehensive insights into early treatment effects in relation to patient reported outcomes, including pain and fatigue. In addition, we are interested to understand how long patients stay on treatment and how this could be affected by patient characteristics or treatment effects.”

About Rheumatoid Arthritis

RA is a chronic inflammatory disease. In RA a person’s immune system attacks healthy cells, causing painful swelling in affected parts of the body, primarily in the joints.1 RA can cause tissue damage resulting in chronic pain, unsteadiness and physical disability.1 More than 2.3 million individuals are living with RA in Europe2 and women are 2 – 3 times more likely to develop RA3. The onset of disease is typically between 30 and 50 years of age4.

About the FILOSOPHY
P
hase 4 study

FILOSOPHY (FILgotinib Observational Study Of Patient Health related outcomes over 2 Years), is a prospective, non-interventional cohort study enrolling approximately 1500 patients across Europe. Data will be collected by the clinical sites and patients using an electronic case report form (eCRF) and mobile devices. Each enrolled patient will be followed for 24 months or until discontinuation of study, whichever occurs first. Baseline assessments may be collected within 30 days prior to the first dose of filgotinib.

The primary objective of the study is to evaluate the treatment persistence rate at 24 months, defined as the rate of patients continuing to receive filgotinib 24 months from treatment initiation. Secondary and exploratory objectives include effectiveness, evaluation of the effect of filgotinib on patient reported outcomes (PROs) including on pain, fatigue and work productivity, rate of adverse events (AEs) and serious adverse events (SAEs) as well as adverse events of interest, including serious and opportunistic infections (including herpes zoster), major adverse cardiovascular events (MACE), venous thromboembolism (VTE), hyperlipidemia, malignancies, non-melanoma skin cancer (NMSC), and gastrointestinal (GI) perforation.

For more information go to ClinicalTrials.gov Identifier: NCT04871919

About filgotinib

Filgotinib is approved and marketed as Jyseleca (200mg and 100mg tablets) in the Europe Union, Great Britain and Japan for the treatment of adults with moderate to severe active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs). Filgotinib may be used as monotherapy or in combination with methotrexate (MTX). The European Summary of Product Characteristics for filgotinib, which includes contraindications and special warnings and precautions, is available at www.ema.europa.eu. The interview form from the Japanese Ministry of Health, Labour and Welfare is available at www.info.pmda.go.jp. The Great Britain Summary of Product Characteristics is available at www.medicines.org.uk/emc. Applications have been submitted to the European Medicines Agency (EMA), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for the treatment of adults with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent and are currently under review. Filgotinib is not approved in any other jurisdictions.

About the
filgotinib collaboration

Gilead and Galapagos NV are collaborative partners in the global development and commercialization of filgotinib. Galapagos will be responsible for the commercialization of filgotinib in Europe (transition anticipated to be completed by end of 2021), while Gilead will remain responsible for filgotinib outside of Europe, including in Japan, where filgotinib is co-marketed with Eisai. Filgotinib in UC has been filed in Europe and Japan and a global Phase 3 program is ongoing in Crohn’s Disease. More information about clinical trials can be accessed at www.clinicaltrials.gov.

About Galapagos

Galapagos NV discovers, develops and commercializes small molecule medicines with novel modes of action, several of which show promising patient results and are currently in late-stage development in multiple diseases. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis and other indications. Our ambition is to become a leading global biotech company focused on the discovery, development and commercialization of innovative medicines. More information at www.glpg.com.

  1. Centers for Disease Control and Prevention. Rheumatoid Arthritis (RA). Available at: https://www.cdc.gov/arthritis/basics/rheumatoid-arthritis.html. Accessed September 2020.
  2. National Rheumatoid Arthritis Society. The Burden of Rheumatoid Arthritis across Europe a Socioeconomic Survey (BRASS). Summary Report. Available at: https://www.nras.org.uk/data/files/Publications/Surveys%20Reports/UoC_HCD_BRASS%20Summary%20Report%20FINAL.pdf. Accessed September 2020
  3. Arthritis Foundation. Arthritis by the Numbers. Available at: https://www.arthritis.org/getmedia/e1256607-fa87-4593-aa8a-8db4f291072a/2019-abtn-final-march-2019.pdf. Accessed September 2020.
  4. Wasserman, A. Diagnosis and Management of Rheumatoid Arthritis. American Family Physician. 2011;84(11):1245-1252.

Contacts

Investors:

Elizabeth Goodwin
VP Investor Relations
+1 781 460 1784

Sofie Van Gijsel
Senior Director Investor Relations
+32 485 19 14 15
[email protected]

Media:

Carmen Vroonen
Global Head of Communications & Public Affairs
+32 473 824 874

Anna Gibbins
Senior Director Therapeutic Areas Communications
+44 7717 801900
[email protected]

Forward-looking statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those referred to in the forward-looking statements and, therefore, the reader should not place undue reliance on them. These risks, uncertainties and other factors include, without limitation, the inherent risks associated with clinical trial and product development activities
, including the FILOSOPHY study
, competitive developments, and regulatory approval requirements,
the risk that the results of the FILOSOPHY study will not support continued approval of
Jyseleca
for the treatment of adults with moderate to severe active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs (DMARDs)
due to safety, efficacy or other reasons
, Galapagos’ reliance on collaborations with third parties, including the collaboration with Gilead for filgotinib
, risks related to the implementation of the transition of European commercialization responsibility to us
, as well as those risks and uncertainties identified in our Annual Report on Form 20-F for the year ended 31 December 2020 and our subsequent filings with the SEC. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. The forward-looking statements contained herein are based on management’s current expectations and beliefs and speak only as of the date hereof, and Galapagos makes no commitment to update or publicly release any revisions to forward-looking statements in order to reflect new information or subsequent events, circumstances or changes in expectations.

 

Attachment